Volume 41, Issue 5, Pages (November 2014)

Slides:



Advertisements
Similar presentations
Volume 5, Issue 3, Pages (March 2016)
Advertisements

Volume 13, Issue 7, Pages (November 2015)
Volume 45, Issue 6, Pages (December 2016)
Volume 33, Issue 1, Pages (July 2010)
Volume 11, Issue 2, Pages (August 2012)
Volume 35, Issue 3, Pages (September 2011)
by Holger Weishaupt, Mikael Sigvardsson, and Joanne L. Attema
Roger B. Deal, Steven Henikoff  Developmental Cell 
Volume 44, Issue 3, Pages (November 2011)
Steven J. Petesch, John T. Lis  Cell 
Volume 7, Issue 1, Pages (July 2010)
Volume 20, Issue 2, Pages (January 2010)
Volume 53, Issue 6, Pages (March 2014)
Volume 38, Issue 1, Pages (January 2013)
Volume 45, Issue 6, Pages (December 2016)
Volume 31, Issue 3, Pages (September 2009)
Volume 28, Issue 2, Pages (August 2015)
Histone Modifications Associated with Somatic Hypermutation
Latent Regulatory Potential of Human-Specific Repetitive Elements
Adrien Le Thomas, Georgi K. Marinov, Alexei A. Aravin  Cell Reports 
Volume 33, Issue 4, Pages (February 2009)
Volume 17, Issue 8, Pages (November 2016)
Volume 8, Issue 1, Pages (January 2011)
Volume 2, Issue 2, Pages (February 2008)
Volume 135, Issue 4, Pages (November 2008)
A Major Epigenetic Programming Mechanism Guided by piRNAs
Volume 55, Issue 3, Pages (August 2014)
Volume 24, Issue 3, Pages (February 2013)
Volume 63, Issue 4, Pages (August 2016)
Volume 35, Issue 4, Pages (October 2011)
Wei Jiang, Yuting Liu, Rui Liu, Kun Zhang, Yi Zhang  Cell Reports 
Volume 44, Issue 3, Pages (November 2011)
Volume 43, Issue 2, Pages (August 2015)
Volume 30, Issue 1, Pages (January 2009)
Volume 37, Issue 6, Pages (December 2012)
Volume 35, Issue 2, Pages (August 2011)
Volume 24, Issue 5, Pages (May 2006)
Dynamic Regulation of Nucleosome Positioning in the Human Genome
Histone Modifications Associated with Somatic Hypermutation
Volume 132, Issue 6, Pages (March 2008)
Volume 36, Issue 4, Pages (February 2016)
Volume 39, Issue 5, Pages (November 2013)
Volume 30, Issue 6, Pages (June 2009)
Volume 122, Issue 6, Pages (September 2005)
Volume 35, Issue 2, Pages (August 2011)
Volume 35, Issue 4, Pages (October 2011)
Polycomb Protein Ezh1 Promotes RNA Polymerase II Elongation
Volume 40, Issue 3, Pages (March 2014)
Volume 21, Issue 12, Pages (December 2017)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Volume 22, Issue 3, Pages (March 2005)
Volume 6, Issue 5, Pages (May 2010)
Volume 16, Issue 6, Pages (December 2012)
Volume 63, Issue 3, Pages (August 2016)
Volume 20, Issue 13, Pages (September 2017)
Volume 7, Issue 2, Pages (August 2010)
Volume 9, Issue 3, Pages (November 2014)
Volume 32, Issue 6, Pages (June 2010)
Volume 39, Issue 3, Pages (September 2013)
Volume 27, Issue 5, Pages (September 2007)
Volume 133, Issue 5, Pages (May 2008)
Volume 32, Issue 5, Pages (May 2010)
Volume 1, Issue 3, Pages (September 2007)
Volume 17, Issue 3, Pages (September 2009)
Volume 40, Issue 2, Pages (February 2014)
Volume 17, Issue 3, Pages (October 2016)
Volume 20, Issue 13, Pages (September 2017)
Volume 64, Issue 5, Pages (December 2016)
Volume 35, Issue 3, Pages (September 2011)
Volume 39, Issue 2, Pages (August 2013)
Presentation transcript:

Volume 41, Issue 5, Pages 853-865 (November 2014) Distinct Epigenetic Signatures Delineate Transcriptional Programs during Virus-Specific CD8+ T Cell Differentiation  Brendan E. Russ, Moshe Olshanksy, Heather S. Smallwood, Jasmine Li, Alice E. Denton, Julia E. Prier, Angus T. Stock, Hayley A. Croom, Jolie G. Cullen, Michelle L.T. Nguyen, Stephanie Rowe, Matthew R. Olson, David B. Finkelstein, Anne Kelso, Paul G. Thomas, Terry P. Speed, Sudha Rao, Stephen J. Turner  Immunity  Volume 41, Issue 5, Pages 853-865 (November 2014) DOI: 10.1016/j.immuni.2014.11.001 Copyright © 2014 Elsevier Inc. Terms and Conditions

Immunity 2014 41, 853-865DOI: (10.1016/j.immuni.2014.11.001) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 1 Global Histone Methylation and Transcriptional Patterns of Naive, Effector, and Memory OT-I CD8+ T Cells Naive (CD44loCD62Lhi) CD45.1+CD8+ OT-I CTLs were sort purified prior to adoptive transfer into CD45.2+ congenic mice. Mice that had received naive OT-Is were infected with A/HKx31-OVA and effector (CD44hiCD62Llo), and memory (CD44hi) OT-Is were isolated and sort purified either 10 or 60 days after infection, respectively. (A–E) ChIP-seq using an Illumina HiSeq2000 was performed on naive, effector, and memory CD8+ OT-I T cells for both H3K4me3 and H3K27me3 histone PTMs. Data were mapped back to the mouse genome (version mm10). (A) Shown is the proportion of H3K4me3 or H3K27me3 sequence tags that mapped to promoter regions (−3 kb to +1 kb around the TSS, black bars), the gene body (+ 1 kb TSS to 3′ UTR, white bars), or intergenic regions (gray bars). (B) Gene promoters that exhibited differences in H3K4me3 or H3K27me3 enrichment were identified and the data transformed (log2) and converted into a heatmap (described in the Experimental Procedures). Hierarchical clustering was then used to determine the relationship of histone methylation patterns observed in the promoter region between naive, effector, and memory CTL subsets. (C and D) The number of gene loci that exhibited differences in histone methylation patterns (C) within the promoter region was determined as described in the Experimental Procedures. Shown is the proportion (C) and number (D) of genes that exhibited distinct patterns of H3K4me3 (blue) or H3K27me3 (red) peaks between naive, effector, and memory OT-Is. (E) The number of differentially expressed (DE, log2 > 1.7) genes that were either upregulated or downregulated between naive (blue), effector (red), and memory (green) CTL subsets. (F–H) The difference in H3K4me3 (green) or H3K27me3 (red) sequence tag density was determined for promoters identified with distinct patterns of peak enrichment (C and D) for effector versus naive (F), memory versus naive (G), and memory versus effector (H) CTL subsets. This was then correlated against the log2FC of DE gene expression between the same groups: effector versus naive (F), memory versus naive (G), and memory versus effector (H). See also Figures S1 and S2 and Tables S1 and S2. Immunity 2014 41, 853-865DOI: (10.1016/j.immuni.2014.11.001) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 2 Histone Methylation Patterns Identify Gene Cohorts with Distinct Functional Roles during CTL Differentiation (A) The number of H3K4me3 or H3K27me3 sequences tags from −3 kb to +1 kb around the TSS for genes known to have roles in CTL differentiation (listed in Table S3) was transformed (log2) and converted into a heatmap (described in the Experimental Procedures). Hierarchical clustering was then used to determine the relationship of histone methylation patterns observed in the promoter regions between the listed genes. Shown is the order of genes after clustering. (B–G) The ratio of sequence tags for H3K4me3 (B–D) or H3K27me3 (E–G) were correlated with the log2 fold change in transcriptional mRNA expression between naive, effector, and memory CTL subsets as described in Figure 1 for the gene listed in Table S3. Immunity 2014 41, 853-865DOI: (10.1016/j.immuni.2014.11.001) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 3 Dynamic Changes in H3K4me3 and H3K27me3 Enrichment upon T Cell Activation (A–F) Shown is the pattern of H3K4me3 (red, above line) and H3K27me3 (blue, below line) peaks within the promoter, gene body, and 3′ UTR regions of CTL effector gene loci within naive, effector, and memory OT-Is. (G and H) ChIP for either H3K4me3 (G) or H3K27me3 (H) was performed on naive OT-Is (white bars) or OT-Is stimulated with OVA257 peptide for 5 (gray bars) or 24 (black bars) hr. Enrichment for H3K4me3 or H3K27me3 was determined by qPCR, with primers that targeted the proximal promoter just upstream of the TSS (inset) of the specific gene loci. Error bars show ± standard deviation of triplicate samples. Also see Figures S2–S4. Immunity 2014 41, 853-865DOI: (10.1016/j.immuni.2014.11.001) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 4 H3K4me2 Marks a Subset of Rapidly Transcribed Effector Gene Loci in Naive CTLs (A) Shown are the patterns of H3K4me2 (red, above line) and H3K4me3 (blue, below line) peaks within the promoter, gene body, and 3′ UTR of genes within naive and effector OT-I CD8+ T cells. (B) ChIP for either H3K4me3, H3K27me3, or H3K4me2 was performed on naive CD8+ T cells (white bars) or OT-I CD8+ T cells stimulated with OVA257 peptide for 5 (gray bars) or 24 (black bars) hr. Enrichment for H3K4me3, H3K27me3, or H3K4me2 was determined by qPCR, via primers that targeted the proximal promoter just upstream of the TSS (inset) of the specific genes. Error bars show ± standard deviation of triplicate samples. Immunity 2014 41, 853-865DOI: (10.1016/j.immuni.2014.11.001) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 5 Bivalent Loci within Naive CTLs Rapidly Resolve to a Permissive H3K4me3+H3K27me3− Methylation Signature (A) Bivalent loci were identified in naive OT-I as having overlapping H3K4me3 and H3K27me3 peaks within 400 bp of each other. Clustering analysis, based on log2 enrichment of histone methylation patterns within the promoter region, was performed to generate a hierarchical list and the histone methylation patterns in effector and memory OT-I determined. (B) Methylation patterns of genes that were bivalent in naive cells were determined in effector and memory CTL populations. Shown is the proportion of genes that lost H3K27me3 (K4+K27−, red), lost H3K4me3 (K4−K27+, green), or lost both methylation marks (K4−K27−, purple) in effector (E), memory (M), or both effector and memory (E+M) subsets. (C–F) Shown is the pattern of H3K4me3 (red, above line) and H3K27me3 (blue, below line) enrichment within the promoter, gene body, and 3′ UTR of bivalent genes within naive, effector, and memory OT-I CD8+ T cells. (G–J) Sequential ChIP was performed on sort-purified naive (CD44loCD62Lhi) OT-I CD8+ T cells by first immunoprecipitation with antibodies specific for H3K4me3 (G) or H3K27me3 (H) with samples probed for enrichment by RT-PCR via primers that targeted a 400 bp region just upstream of the TSS. These samples were then immunoprecipitated a second time with antibodies specific for either H3K27me3 (I) or H3K4me3 (J) and samples probed for enrichment as above. (K–M) ChIP for either H3K4me3 (white bars) or H3K27me3 (black bars) was performed on naive OT-I CD8+ T cells (K) or OT-I CD8+ T cells stimulated with OVA257 peptide for 5 (L) or 24 (M) hr. Enrichment for H3K4me3 or H3K27me3 was determined by qPCR, via primers that targeted the proximal promoter just upstream of the TSS (inset). Error bars show ± standard deviation of triplicate samples. See also Tables S1 and S2 and Figures S4 and S5. Immunity 2014 41, 853-865DOI: (10.1016/j.immuni.2014.11.001) Copyright © 2014 Elsevier Inc. Terms and Conditions